Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Gaurav Mehta from Industrial Alliance Securities issued a price target of $19.00 for PINE on 2025-04-25 16:47:11.The adjusted price target was set to $19.00.At the time of the announcement,...
April 25, 2025 PINE 0.78%
Ashwani Verma from UBS issued a price target of $1.05 for CHRS on 2025-04-24 13:04:08.The adjusted price target was set to $1.05.At the time of the announcement, CHRS...
April 24, 2025 CHRS -5.76%
Gaurav Mehta from Industrial Alliance Securities issued a price target of $1.25 for SACH on 2025-03-28 11:13:23.The adjusted price target was set to $1.25.At the time of the announcement,...
March 28, 2025 SACH -2.50%
from Roth Capital issued a price target of $5.40 for MGRM on 2025-03-18 11:46:08.The adjusted price target was set to $5.40.At the time of the announcement, MGRM...
March 18, 2025 MGRM 1.90%
from Roth Capital issued a price target of $2.00 for SOL on 2025-03-14 16:42:38.The adjusted price target was set to $2.00.At the time of the announcement, SOL...
March 18, 2025 SOL -3.24%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| CARM Carisma Therapeutics, Inc | 1.11
389.42% | ||||||||||||||||||
| NKTR Nektar Therapeutics | 11.35
29.12% | ||||||||||||||||||
| JSPRW Jasper Therapeutics Inc | 0.11
21.71% | ||||||||||||||||||
| MAPSW WM Technology Inc | 0.02
21.68% | ||||||||||||||||||
| CATO The Cato Corporation | 3.05
17.76% | ||||||||||||||||||
| PROF Profound Medical Corp. | 6.75
17.39% | ||||||||||||||||||
| ORGNW Origin Materials Inc Warr | 0.03
16.36% | ||||||||||||||||||
| RMBL RumbleON, Inc. | 2.39
15.46% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 3.50%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW 0.77%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -2.63%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 2.07%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 1.66%